Spontaneous chronic epidural hematoma in the lumbar spine associated with Warfarin intake: a case report

Axel Sandvig1, Håkan Jonsson2

  • 1Division of Neurosurgery and Clinical Neurophysiology, Department of Pharmacology and Clinical Neurosciences, Umeå University Hospital, Umeå, Sweden ; Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway.

Springerplus
|November 8, 2016
PubMed
Abstract

Insights

Spinal epidural hematomas are rare but can occur in patients taking warfarin. This case highlights how these hematomas may mimic disc issues, emphasizing the need for awareness in anticoagulated individuals.

Area of Science:

  • Neurology
  • Neurosurgery
  • Radiology

Background:

  • Spontaneous spinal epidural hematomas (SSEH) are uncommon neurological emergencies.
  • Anticoagulant therapy, such as warfarin, may increase the risk of SSEH.
  • Patients may present with radiculopathy or progressive neurological deficits.

Purpose of the Study:

  • To report a case of SSEH in a warfarin-treated patient.
  • To illustrate diagnostic challenges and potential misinterpretations of imaging findings.
  • To emphasize the association between warfarin use and SSEH.

Main Methods:

  • Case presentation of a warfarin-treated patient with L5 radiculopathy.
  • Review of MRI findings initially suggestive of lumbar disc prolapse or synovial cyst.
  • Surgical intervention and histological analysis of removed material confirming hematoma.

Main Results:

  • The patient underwent surgery for suspected disc prolapse/cyst, but a hematoma was found.
  • Histological analysis confirmed the presence of a hematoma, not a disc herniation or cyst.
  • Neurological recovery was achieved post-operatively.

Conclusions:

  • SSEH can present with symptoms mimicking common spinal pathologies like disc herniation.
  • Radiological misinterpretation is possible, particularly in patients on anticoagulants.
  • Warfarin therapy is a potential risk factor for SSEH, necessitating clinical vigilance.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
445
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
352
Disorders of Hemostasis01:24

Disorders of Hemostasis

Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
2.6K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.6K
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.2K
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
618